elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33819361-5AF8D77A-18B7-4FBD-95DF-5876CC03C8F6
Q33819361-5AF8D77A-18B7-4FBD-95DF-5876CC03C8F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33819361-5AF8D77A-18B7-4FBD-95DF-5876CC03C8F6
Accelerator mass spectrometry-enabled studies: current status and future prospects.
P2860
Q33819361-5AF8D77A-18B7-4FBD-95DF-5876CC03C8F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33819361-5AF8D77A-18B7-4FBD-95DF-5876CC03C8F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e70fd066ecff3f4700c42c5cd4c25e4a07353df0
P2860
Characterization of oxaliplatin-DNA adduct formation in DNA and differentiation of cancer cell drug sensitivity at microdose concentrations.